@article{TCR29602,
author = {Sara Elena Rebuzzi and Francesco Facchinetti and Marcello Tiseo},
title = {Anti-angiogenesis boosts chemo-immunotherapy in patients with EGFR mutations or baseline liver metastases: insights from IMpower150 study},
journal = {Translational Cancer Research},
volume = {8},
number = {Suppl 6},
year = {2019},
keywords = {},
abstract = {The first-line treatment scenario of advanced non-small cell lung cancer (NSCLC) has been substantially revolutionized in the very last years, since immunotherapy has become a cornerstone.},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/29602}
}